Asset
Osugacestat
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT04111666 | phase1 | completed | 2019-12-14 | 2022-06-09 | Alector Inc. | A Phase 1 First in Human Study to Assess Safety and Tolerability of AL101 |
FDA applications (0)
This company has no applications containing this asset.